Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lihit LabNGO:7975 63 3-Year EBITDA Growth Rate is 13.80% as of May. 2026, which is 221% above its 10-year median of 4.30. GuruFocus rates NGO:7975 with a GF Score™ of 63/100 and a GF Value™ of 円883.35. The stock has 4 warning signs investors should review. Among 2,605 Industrial Products companies, Lihit Lab ranks better than 67.06% on this metric.
During the past 12 months, Lihit Lab's average EBITDA Per Share Growth Rate was -53.20% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 13.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -10.60% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -6.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Lihit Lab was 44.20% per year. The lowest was -40.80% per year. And the median was 4.30% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
For the Business Equipment & Supplies subindustry, Lihit Lab's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lihit Lab 3-Year EBITDA Growth Rate vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Lihit Lab's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Lihit Lab's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 13.80% mean?
Lihit Lab (NGO:7975) has a 3-Year EBITDA Growth Rate of 13.80% as of May. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Lihit Lab and its competitors. This is 221% above median its historical median of 4.30. According to the industry distribution chart, Lihit Lab ranks #858 out of 2605 companies in the Industrial Products industry, placing it in the top 32.9%.
Is Lihit Lab's 3-Year EBITDA Growth Rate too high?
Lihit Lab's current 3-Year EBITDA Growth Rate of 13.80% is 221% above median its 10-year median of 4.30. The Industrial Products industry median 3-Year EBITDA Growth Rate is 4.50. Lihit Lab's value of 13.80% is 206.7% above this industry median. Based on the distribution chart, Lihit Lab ranks #858 out of 2605 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Lihit Lab has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Lihit Lab's 3-Year EBITDA Growth Rate compare to competitors?
According to the Industrial Products industry distribution chart, Lihit Lab ranks #858 out of 2605 companies for 3-Year EBITDA Growth Rate. This puts Lihit Lab in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 4.50. Lihit Lab's value of 13.80% is 206.7% above this benchmark. While the company's 10-year median is 4.30 vs. the industry median of 4.50, Lihit Lab has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Industrial Products company?
The median 3-Year EBITDA Growth Rate among Industrial Products companies is 4.50, based on 2,605 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lihit Lab's current 3-Year EBITDA Growth Rate of 13.80% is 206.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Lihit Lab and its competitors. For the Industrial Products industry, the median 3-Year EBITDA Growth Rate is 4.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lihit Lab's current 3-Year EBITDA Growth Rate is 13.80%, which is 221% above median its own 10-year median of 4.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lihit Lab stock overvalued right now?
Lihit Lab (NGO:7975) has a current 3-Year EBITDA Growth Rate of 13.80%. The stock's GF Value™ is 円883.35, compared to a current price of 円902.00 — trading 2.1% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 13.80%, which is 221% above median its 10-year median of 4.30 and 206.7% above the Industrial Products industry median of 4.50. Lihit Lab's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Lihit Lab (NGO:7975), the current 3-Year EBITDA Growth Rate is 13.80% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lihit Lab (NGO:7975) Overvalued in 2026?
Based on GuruFocus' analysis, Lihit Lab stock appears to be overvalued.
The current stock price of 円902.00 is trading 2.1% above its estimated GF Value™ of 円883.35.
Key valuation signals for NGO:7975:
3-Year EBITDA Growth Rate: 13.80% (221% above median its 10-year median of 4.30)
GF Value™: 円883.35 vs. price of 円902.00 (2.1% above fair value)
Industry Position: 206.7% above the Industrial Products median (#858 of 2605)
No single metric tells the full story. See the NGO:7975 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lihit Lab Inc is engaged in manufacturing and selling office supplies in Japan and internationally. Its products include files, clear books, clear cases, bag cases, and note binders; card holders, pencil cases, photo postcard albums, clip files, clipboards, and schedule files; drawing organize supplies and steel office equipment; OA and medical surprise products; and office devices.
63GF Score
Get the complete analysis for NGO:7975
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGO:7975 has been successfully added to your 
